CDC20siRNA and paclitaxel co-loaded nanometric liposomes of a nipecotic acid-derived cationic amphiphile inhibit xenografted neuroblastoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CDC20siRNA and paclitaxel co-loaded nanometric liposomes of a nipecotic acid-derived cationic amphiphile inhibit xenografted neuroblastoma
Authors
Keywords
-
Journal
Nanoscale
Volume 9, Issue 3, Pages 1201-1212
Publisher
Royal Society of Chemistry (RSC)
Online
2016-12-06
DOI
10.1039/c6nr07532k
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
- (2016) Donna L. Nile et al. BMC CANCER
- Neuroblastoma: Molecular Pathogenesis and Therapy
- (2015) Chrystal U. Louis et al. Annual Review of Medicine
- Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion
- (2015) Irene Cossu et al. BIOMATERIALS
- CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus
- (2015) M. R. Russell et al. CANCER RESEARCH
- Advances in Risk Classification and Treatment Strategies for Neuroblastoma
- (2015) Navin R. Pinto et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Cdc20 as a novel cancer therapeutic strategy
- (2015) Lixia Wang et al. PHARMACOLOGY & THERAPEUTICS
- Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
- (2015) Daniel R. Carter et al. Science Translational Medicine
- Common Genetic Variants in NEFL Influence Gene Expression and Neuroblastoma Risk
- (2014) M. Capasso et al. CANCER RESEARCH
- APCCdc20 Suppresses Apoptosis through Targeting Bim for Ubiquitination and Destruction
- (2014) Lixin Wan et al. DEVELOPMENTAL CELL
- miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin
- (2014) Kristina Althoff et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibiting tumor growth by targeting liposomally encapsulated CDC20siRNA to tumor vasculature: Therapeutic RNA interference
- (2014) Poulami Majumder et al. JOURNAL OF CONTROLLED RELEASE
- Rare Variants in TP53 and Susceptibility to Neuroblastoma
- (2014) Sharon J. Diskin et al. JNCI-Journal of the National Cancer Institute
- Expression Quantitative Trait Loci and Receptor Pharmacology Implicate Arg1 and the GABA-A Receptor as Therapeutic Targets in Neuroblastoma
- (2014) Christopher S. Hackett et al. Cell Reports
- Different strategies to overcome multidrug resistance in cancer
- (2013) Manju Saraswathy et al. BIOTECHNOLOGY ADVANCES
- New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK
- (2013) G. Barone et al. CLINICAL CANCER RESEARCH
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Promising Therapeutic Targets in Neuroblastoma
- (2012) K. K. Matthay et al. CLINICAL CANCER RESEARCH
- Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
- (2012) Priyambada Parhi et al. DRUG DISCOVERY TODAY
- Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy
- (2012) Yuling Xiao et al. Nanoscale
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- (2012) Jan J Molenaar et al. NATURE GENETICS
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
- (2012) Mark Sausen et al. NATURE GENETICS
- Targeting ALK in neuroblastoma—preclinical and clinical advancements
- (2012) Erica L. Carpenter et al. Nature Reviews Clinical Oncology
- Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
- (2012) L. C. Heukamp et al. Science Translational Medicine
- Integrative genomics identifies LMO1 as a neuroblastoma oncogene
- (2010) Kai Wang et al. NATURE
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Polymeric nanoparticles for siRNA delivery and gene silencing
- (2008) Yogesh Patil et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now